GlassScriptPhysician profile
Michael H Lemus
NPI 1326355660
$2,231.17
in general payments reported to CMS, 2019-2025
36 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $764 · 2022: $332 · 2023: $497 · 2024: $234 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $395.56 | 2021-2024 | |
| Abbvie INC. | $268.77 | 2023-2025 | |
| Novo Nordisk INC | $179.51 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $118.11 | 2021-2022 | |
| Organogenesis INC. | $117.80 | 2022 | |
| Amgen INC. | $96.20 | 2023 | Prolia, Evenity, Otezla |
| Pharmacyclics LLC, An Abbvie Company | $87.63 | 2023 | Epkinly, Imbruvica |
| Exelixis INC. | $75.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $70.46 | 2021 | |
| Medtronic, INC. | $66.05 | 2023-2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Pfizer INC. | $64.78 | 2023-2025 | |
| Lilly USA, LLC | $57.24 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $53.54 | 2023 | Freestyle Libre 2 |
| Janssen Biotech, INC. | $53.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.19 | 2021-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $39.24 | 2021 | |
| Celgene Corporation | $38.56 | 2021 | |
| Esperion Therapeutics, INC. | $33.00 | 2023-2024 | Nexletol |
| Boston Scientific Corporation | $30.80 | 2025 | Infinion 16 |
| Exact Sciences Corporation | $30.72 | 2024 | Cologuard Collection Kit |
| Emd Serono, INC. | $29.10 | 2021 | |
| Seagen INC. | $27.21 | 2021 | |
| Hologic Sales and Service, LLC | $24.15 | 2025 | Thinprep 2000 Processor, Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.24 | 2025 | Xifaxan |
| Lundbeck LLC | $22.20 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.94 | 2023 | |
| Morphosys, US INC. | $20.26 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $19.01 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.52 | 2023 | Xarelto |
| Epizyme, INC. | $17.95 | 2021 | |
| Coherus Oncology, INC. | $16.87 | 2021 | |
| Acrotech Biopharma INC. | $15.88 | 2021 | |
| Kite Pharma, INC. | $15.23 | 2021 | |
| Taiho Oncology, INC. | $14.87 | 2021 | |
| Beigene USA, INC. | $12.66 | 2021 | |
| Merck Sharp & Dohme LLC | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lemus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.